Amiloride HCl - CAS 2016-88-8
Catalog number: 2016-88-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C6H8ClN7O.HCl
Molecular Weight:
266.09
COA:
Inquire
Targets:
Sodium Channel
Description:
Amiloride HCl is a relatively selective inhibitor of the epithelial sodium channel (ENaC), used in the management of hypertension and congestive heart failure.
Purity:
>98%
MSDS:
Inquire
InChIKey:
ACHKKGDWZVCSNH-UHFFFAOYSA-N
InChI:
InChI=1S/C6H8ClN7O.ClH/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11;/h(H4,8,9,13)(H4,10,11,14,15);1H
Canonical SMILES:
C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl
1.5'-Substituted amiloride derivatives as allosteric modulators binding in the sodium ion pocket of the adenosine A2A receptor.
Massink A, Louvel JA, Adlere I, van Veen C, Huisman BJ, Dijksteel GS, Guo D, Lenselink EB, Buckley BJ, Matthews H, Ranson M, Kelso MJ, IJzerman AP. J Med Chem. 2016 Apr 28. [Epub ahead of print]
The sodium ion site is an allosteric site conserved amongst many G protein-coupled receptors (GPCRs). Amiloride 1 and 5-(N,N-hexamethylene)amiloride 2 (HMA) supposedly bind in this sodium ion site and can influence orthosteric ligand binding. The availability of a high resolution X-ray crystal structure of the human adenosine A2A receptor (hA2AAR), in which the allosteric sodium ion site was elucidated, makes it an appropriate model receptor for investigating the allosteric site. In this study, we report the synthesis and evaluation of novel 5'-substituted amiloride derivatives as hA2AAR allosteric antagonists. Potency of the amiloride derivatives was assessed by their ability to displace the orthosteric radioligand [3H]4-(2-((7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a]-[1,3,5]triazin-5-yl)amino)ethyl)phenol ([3H]ZM-241,385) from both the wild-type and sodium ion site W246A mutant hA2AAR. 4-Ethoxyphenethyl substituted amiloride 12l was found to be more potent than both amiloride and HMA, and the potency-shift between the wild-type and mutated receptor confirmed its likely binding to the sodium ion site.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Sodium Channel Products


Eleclazine
(CAS: 1443211-72-0)

Eleclazine is a selective Sodium channel antagonist. Eleclazin showed a shortening of the QTc interval (the time interval between the start of the Q-wave and en...

Nav1.7 inhibitor
(CAS: 1355631-24-1)

Nav1.7 inhibitor is a Voltage-gated sodium channel inhibitor that have probable effect in pain therapy and local anaesthesia.

OD1

OD1 is a rat Nav1.7, human Nav1.4 and rat Nav1.6 channel activator. It exhibits minimal activation at mammalian Nav1.2, Nav1.3 and Nav1.5. OD1 can induce sponta...

CAS 42971-09-5 Vinpocetine

Vinpocetine
(CAS: 42971-09-5)

Vinpocetine is a Phosphodiesterase inhibitor and selective for PDE1. It also blocks voltage-gated Na+ channels.

Sodium Channel inhibitor 1
(CAS: 1198117-23-5)

Sodium Channel inhibitor 1, a 3-Oxoisoindoline-1-carboxamide derivative, is an effective voltage-gated sodium channel blocker that could be used for pain treatm...

CAS 1262618-39-2 GS967

GS967
(CAS: 1262618-39-2)

GS967, also known as GS-458967, is a highly selective late sodium channel current blocker. The selective inhibition of late INa with GS967 can exert antiarrhyth...

CAS 396-01-0 Triamterene

Triamterene
(CAS: 396-01-0)

Triamterene blocks epithelial Na+ channel (ENaC) in a voltage-dependent manner with IC50 of 4.5 μM.

CAS 5369-00-6 QX 222

QX 222
(CAS: 5369-00-6)

QX 222, a quaternary ammonium derivative of lidocaine, is a sodium channel blocker.

Chemical Structure

CAS 2016-88-8 Amiloride HCl

Quick Inquiry

Verification code

Featured Items